Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
John G F ClelandPhilip A KalraPierpaolo PellicoriFraser J GrahamPaul W X FoleyIain B SquirePeter J CowburnAlison SeedAndrew L ClarkBen SzwejkowskiPrithwish BanerjeeJustin CookeMark FrancisPiers CliffordAaron WongColin PetrieJohn J V McMurrayElizabeth A ThomsonKirsty WetherallMichele RobertsonIan FordPaul R Kalranull nullPublished in: European heart journal (2024)
This hypothesis-generating analysis suggests that anaemia or TSAT < 20% with ferritin > 100 µg/L might identify patients with heart failure who obtain greater benefit from intravenous iron. This interpretation requires confirmation.